Results 151 to 160 of about 23,240 (264)

DENDRIMER CONJUGATES FOR SELECTIVE OF PROTEIN AGGREGATES

, 2004
Dendrimer conjugates are presented, which are formed between a dendrimer and a protein solubilising substance. Such dendrimer conjugates are effective in the treatment of protein aggregate-related diseases (e.g. prion-related diseases).
Heegaard, Peter M. H., Boas, Ulrik
core  

Development and evaluation of glycine conjugated polypropyleneimine dendrimers for targeted chloroquine delivery. [PDF]

Discov Nano
Saraogi GK, Parashar AK, Yasin HKA, Ahirwar J, Kumari M.   +4 more
europepmc   +1 more source

A thermoplastic microfluidic platform with integrated electrospun scaffolds for assessing brain cell‐specific drug selectivity

VIEW, Volume 7, Issue 3, June 2026.
Schematic representation of the microfluidic platform with its advantages. Abstract A major challenge in pharmacology is the limited selectivity of therapeutic compounds toward specific tissues or cells. Drugs often distribute systemically before reaching the intended site of action, affecting nontarget cells and potentially reducing efficacy or ...
Maria Testa, Laura Palumbo, Martina La Rosa, Antonella Girgenti, Fabio Salvatore Palumbo, Pasquale Picone, Francesco Lopresti, Domenico Nuzzo, Vincenzo La Carruba   +8 more
wiley   +1 more source

Azobenzene Core Dendrimers with Trityl Groups in the Periphery

Dendrimers are assembled step by step and can be easily customized at each level of their structure (core, branches, and surface), resulting in well defined and highly functionalized three-dimensional architectures.
Kampars, Valdis, Laipniece, Lauma
core  

Investigating the cytotoxic effect of polyethyleneimine nanodendrimer on fibroblast cells. [PDF]

Int J Physiol Pathophysiol Pharmacol
Nazeri S, Saeedi A, Hayati A, Ghaderi P, Vajari SF, Deravi N, Fathiazar A, Namadkolahi R.   +7 more
europepmc   +1 more source

Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease

Clinical and Translational Medicine, Volume 16, Issue 6, June 2026.
Michael Crompton, Raina D. Ramnath, Kai Betteridge, Sara Desideri, Aldara Martin Alonso, Lulu Jiang, Monica Gamez, Holly Stowell‐Connolly, Viktoriia Vasylchenko, Karen L. Onions, Matthew J. Butler, Chris R. Neal, Andrew H. J. Salmon, Jeremy E. Turnbull, Hiroshi Kawachi, Olga V. Zubkova, Gavin I. Welsh, Simon C. Satchell, Rebecca R. Foster   +18 more
wiley   +1 more source

Ligand‐specific tuning of CLEC10A signalling strength and dendritic cell responses through engagement of different GalNAc‐containing glycan structures

The FEBS Journal, Volume 293, Issue 11, Page 3187-3210, June 2026.
The authors investigated the effects of various glycan ligands for CLEC10A, a lectin receptor expressed on dendritic cells (DCs). Monocyte‐derived DCs were stimulated with glycan‐conjugated dendrimers in combination with the TLR1/2 ligand Pam3CysK4, and responses were investigated at the mRNA and protein level.
Nadia L. van der Meijs, Remi Hatinguais, Mike de Kok, R. J. Eveline Li, Tesfay M. Godefa, Victor L. J. L. Thijssen, Yvette van Kooyk, Sandra J. van Vliet   +7 more
wiley   +1 more source

A novel computational study of reverse degree topological indices and entropies for nanostar dendrimers. [PDF]

Sci Rep
Qummer AA, Saqib M, Ali S, Ashebo MA, Jumaniyazov S.   +4 more
europepmc   +1 more source

Carbosilane Dendrimers

, 2009
Roovers, Jacques, Ding, Jianfu
openaire   +2 more sources

Non-Invasive Brain Delivery of G4 70/30 PAMAM Dendrimers via the Intranasal Route. [PDF]

ACS Chem Neurosci
Allahyarzadeh Khiabani N, Elmhirst AR, Dubey O, Poudel A, Singh M, Monville H, Sahouri A, Alani Y, Swanson D, Dunbar GL, Rossignol J.   +10 more
europepmc   +1 more source